News

Latest

News

Innovative agreement launches affordable, optimal second-line HIV treatment in low- and middle-income countries

Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV Geneva, 26 July 2021 – Unitaid and CHAI today announced a groundbreaking pricing agreement with pharmaceutical company Hetero Labs LTD to make darunavir boosted […]

Jul 26th, 2021
News

FIND and Unitaid invest to support technology transfer and boost local production of COVID-19 rapid tests in low- and middle-income countries

Technology transfer agreements signed to enable expanded production of high-quality antigen rapid tests in Africa and Latin America Agreements signed with DCN Dx to transfer know-how to WAMA Diagnóstica (Brazil), and Bionote and Mologic to transfer know-how to DIATROPIX of the Institut Pasteur de Dakar (Senegal) Separate partnership between Viatris (South Africa) and Guangzhou Wondfo Biotech […]

Jul 15th, 2021
HEADLINE NEWS

News: New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide

The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals. PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria. Geneva/Seattle, 14 July 2021 – The new Partnership […]

Jul 14th, 2021
News

Unitaid statement on WHO recommendations for tocilizumab and sarilumab

Geneva, 7 July 2021 – Unitaid welcomes new recommendations released by the World Health Organisation for the clinical care package for patients with severe or critical COVID-19, adding two medicines (tocilizumab and sarilumab). Having more treatment options is clearly of huge benefit, especially given the current concerning epidemiological situation around the world. Equitable access arrangements for medicines to treat […]

Jul 7th, 2021